225 related articles for article (PubMed ID: 10070926)
1. Intravenous iron supplementation in end-stage renal disease patients.
Matzke GR
Am J Kidney Dis; 1999 Mar; 33(3):595-7. PubMed ID: 10070926
[No Abstract] [Full Text] [Related]
2. Sodium ferric gluconate complex in sucrose is safe and effective in hemodialysis patients: North American Clinical Trial.
Nissenson AR; Lindsay RM; Swan S; Seligman P; Strobos J
Am J Kidney Dis; 1999 Mar; 33(3):471-82. PubMed ID: 10070911
[TBL] [Abstract][Full Text] [Related]
3. Safety and efficacy of sodium ferric gluconate complex in iron-deficient pediatric hemodialysis patients.
Kaskel FJ
Nat Clin Pract Nephrol; 2006 May; 2(5):244-5. PubMed ID: 16932433
[No Abstract] [Full Text] [Related]
4. Low-dose intravenous iron administration in chronic hemodialysis patients treated with recombinant human erythropoietin.
Harmankaya O; Eran A
Ren Fail; 2002 Mar; 24(2):245-7. PubMed ID: 12071600
[TBL] [Abstract][Full Text] [Related]
5. Sodium ferric gluconate complex therapy in anemic children on hemodialysis.
Warady BA; Zobrist RH; Wu J; Finan E;
Pediatr Nephrol; 2005 Sep; 20(9):1320-7. PubMed ID: 15971073
[TBL] [Abstract][Full Text] [Related]
6. [Iron replacement in hemodialysis patients with a normal serum ferritin level].
Riedel MK; Morgenstern T
Dtsch Med Wochenschr; 2004 Sep; 129(36):1849-53. PubMed ID: 15368155
[TBL] [Abstract][Full Text] [Related]
7. Achieving target hematocrit in dialysis patients: new concepts in iron management.
Nissenson AR
Am J Kidney Dis; 1997 Dec; 30(6):907-11. PubMed ID: 9398140
[TBL] [Abstract][Full Text] [Related]
8. Review of available intravenous iron preparations in hemodialysis.
Palmer K; Cameron K; Battistella M
CANNT J; 2013; 23(2):51-4; quiz 55-6. PubMed ID: 24069699
[No Abstract] [Full Text] [Related]
9. Comparison of two iron gluconate treatment modalities in chronic hemodialysis patients: results of a randomized trial.
Giordano A; Arrigo G; Lavarda F; Colasanti G; Petrini C
J Nephrol; 2005; 18(2):181-7. PubMed ID: 15931646
[TBL] [Abstract][Full Text] [Related]
10. Implementing continuous quality improvement strategies for improving iron replacement in hemodialysis patients.
Trenkle JA
Nephrol Nurs J; 2001 Oct; 28(5):561-5. PubMed ID: 12143432
[TBL] [Abstract][Full Text] [Related]
11. Intravenous iron in chronic kidney disease: haemoglobin change shortly after treatment of patients neither on dialysis nor on erythropoietin.
Tagboto S; Cropper L; Mostafa S; Turner J; Bailey G; Pugh-Clarke K
J Ren Care; 2008 Sep; 34(3):112-5. PubMed ID: 18786076
[TBL] [Abstract][Full Text] [Related]
12. [Factors influencing responsiveness to treatment in children with renal anemia in end stage renal disease].
Haliţchi CI; Munteanu M; Brumariu O
Rev Med Chir Soc Med Nat Iasi; 2008; 112(1):94-9. PubMed ID: 18677909
[TBL] [Abstract][Full Text] [Related]
13. [Iron supplementation in chronic kidney disease].
Graczyk M; Dylewska M
Wiad Lek; 2017; 70(6 pt 2):1215-1218. PubMed ID: 29533917
[TBL] [Abstract][Full Text] [Related]
14. [Current recommendations for the treatment of iron deficiency anemia].
Schaefer RM; Huch R; Krafft A;
Rev Med Suisse; 2007 Apr; 3(105):874-80. PubMed ID: 17514929
[TBL] [Abstract][Full Text] [Related]
15. Influence of intravenous iron therapy on novel markers of iron deficiency.
Chinnappa S; Bhandari S
Int J Artif Organs; 2010 May; 33(5):297-301. PubMed ID: 20593351
[TBL] [Abstract][Full Text] [Related]
16. Iron supplementation in haemodialysis--practical clinical guidelines.
Silva J; Andrade S; Ventura H; Santos JP; Colaço S; Oliveira C; Ponce P
Nephrol Dial Transplant; 1998 Oct; 13(10):2572-7. PubMed ID: 9794562
[TBL] [Abstract][Full Text] [Related]
17. Weekly low-dose treatment with intravenous iron sucrose maintains iron status and decreases epoetin requirement in iron-replete haemodialysis patients.
Schiesser D; Binet I; Tsinalis D; Dickenmann M; Keusch G; Schmidli M; Ambühl PM; Lüthi L; Wüthrich RP
Nephrol Dial Transplant; 2006 Oct; 21(10):2841-5. PubMed ID: 16891647
[TBL] [Abstract][Full Text] [Related]
18. Erythropoietin therapy in pre-dialysis patients with chronic renal failure: lack of need for parenteral iron.
Trivedi HS; Brooks BJ
Am J Nephrol; 2003; 23(2):78-85. PubMed ID: 12481145
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of oral and intravenous iron therapy in haemodialysis patients.
Jenq CC; Tian YC; Wu HH; Hsu PY; Huang JY; Chen YC; Fang JT; Yang CW
Int J Clin Pract; 2008 Mar; 62(3):416-22. PubMed ID: 17511797
[TBL] [Abstract][Full Text] [Related]
20. Iron replacement in rHuEPO-treated dialysis patients: DOQI and beyond.
Mittman N
Am J Kidney Dis; 1999 Jul; 34(1):173-6. PubMed ID: 10401035
[No Abstract] [Full Text] [Related]
[Next] [New Search]